Clinical Genetic Sequencing and Reporting Tender

Clinical Genetic Sequencing and Reporting Tender

Cambridge University Hospital requires a large number of clinical samples, to be sequenced and reported.

United Kingdom-Cambridge: Blood analysis services

2020/S 059-142747

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Cambridge University Hospitals NHS Foundation Trust
Postal address: Hills Rd
Town: Cambridge
NUTS code: UKH12
Postal code: CB2 0QQ
Country: United Kingdom
E-mail: susan.mulcock@addenbrookes.nhs.uk
Telephone: +44 1223274305
Internet address(es):Main address: www.cuh.nhs.uk/addenbrookes-hospital

I.2)Information about joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: www.cuh.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://eoecph.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Clinical Genetic Sequencing and Reporting

Reference number: ADD/PU/SM/19/31

II.1.2)Main CPV code

85111810

II.1.3)Type of contract

Services

II.1.4)Short description:

Cambridge University Hospital (CUH) requires a large number of clinical samples, to be sequenced and reported.

II.1.5)Estimated total value

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)

II.2.3)Place of performance

NUTS code: UKH12

II.2.4)Description of the procurement:

Cambridge University Hospital (CUH) requires a large number of clinical samples, to be sequenced and reported (minimum 4 500, estimated total 5 000). All samples have been referred to CUH from clinicians requesting clinical genetic testing for a wide range of different inherited diseases. Approximately 20 % of samples are estimated to have pathogenic or likely pathogenic variants that require full clinical interpretation and reporting.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 5
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 23/04/2020
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender

IV.2.7)Conditions for opening of tenders

Date: 23/04/2020
Local time: 13:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about electronic workflows
VI.3)Additional information:
VI.4)Procedures for review

VI.4.1)Review body

Official name: Cambridge University Hospitals NHS Foundation Trust
Town: Cambridge
Country: United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

20/03/2020